Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study

Background Objective measures are required that may be used as a proxy for exacerbations in asthma. The aim was to determine the sensitivity and specificity of electronic diary data to detect severe exacerbations (SEs) of asthma. A secondary aim was to identify phenotypic variables associated with a higher risk of exacerbation. Methods In the BIOAIR study, 169 patients with asthma (93 severe (SA); 76 mild to moderate (MA)) recorded lung function, symptoms and medication use in electronic diaries for 1 year. Data were analysed using receiver-operator characteristics curves and related to physician-diagnosed exacerbations. Medical history and baseline clinical data were used to assess risk of exacerbation. Results Of 122 physician-diagnosed exacerbations, 104 occurred in the SA group (1.1 per patient/year), 18 in the MA group (0.2 per patient/year) and 63 were severe using American Thoracic Society/European Respiratory Society criteria. During exacerbations, peak expiratory flow (PEF) and forced expiratory volume in 1 s significantly decreased, whereas day and night symptoms significantly increased. An algorithm combining a 20% decrease in PEF or a 20% increase in day symptoms on 2 consecutive days was able to detect SEs with 65% sensitivity and 95% specificity. The strongest risk factors for SEs were low Asthma Control Questionnaire score, sputum eosinophils ≥3%, body mass index >25 and low quality of life (St George's Respiratory Questionnaire), with ORs between 3.61 and 2.22 (p<0.05). Conclusions Regular electronic monitoring of PEF and asthma symptoms provides an acceptable sensitivity and specificity for the detection of SEs and may be suitable for personal internet-based monitoring of asthma control.

[1]  S. Dahlén,et al.  Will recording of lung function fluctuation open the door to internet-guided treatment of asthma? , 2011, Thorax.

[2]  Urs Frey,et al.  Predicting future risk of asthma exacerbations using individual conditional probabilities. , 2011, The Journal of allergy and clinical immunology.

[3]  S. Wenzel,et al.  Associations between fluctuations in lung function and asthma control in two populations with differing asthma severity , 2011, Thorax.

[4]  S. Dahlén,et al.  Exacerbations In Severe Asthma - 1 Year Follow Up In The BIOAIR Study , 2011, ATS 2011.

[5]  Peter J Sterk,et al.  Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI) , 2010, Thorax.

[6]  Martyn R Partridge,et al.  Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. , 2010, The Journal of allergy and clinical immunology.

[7]  G. Wennergren,et al.  Problematic severe asthma in children, not one problem but many: a GA2LEN initiative , 2009, European Respiratory Journal.

[8]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[9]  D. Curran‐Everett,et al.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[10]  P. O'Byrne,et al.  Exacerbations of Asthma , 2007 .

[11]  S. Holgate,et al.  The mechanisms, diagnosis, and management of severe asthma in adults , 2006, The Lancet.

[12]  N. Zamel,et al.  Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. , 2006, Chest.

[13]  W. Assendelft,et al.  Compliance and reliability of electronic PEF monitoring in adolescents with asthma , 2006, Thorax.

[14]  J. Molina,et al.  An international observational prospective study to determine the cost of asthma exacerbations (COAX). , 2006, Respiratory medicine.

[15]  Arnab Majumdar,et al.  Risk of severe asthma episodes predicted from fluctuation analysis of airway function , 2005, Nature.

[16]  A. Zwinderman,et al.  Risk factors of frequent exacerbations in difficult-to-treat asthma , 2005, European Respiratory Journal.

[17]  D. Postma,et al.  The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma , 2003, European Respiratory Journal.

[18]  C. Jenkins,et al.  Optimal asthma control, starting with high doses of inhaled budesonide. , 2000, The European respiratory journal.

[19]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[20]  D. Postma,et al.  Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. , 1999, American journal of respiratory and critical care medicine.

[21]  L. Boulet,et al.  Compliance with peak expiratory flow monitoring in home management of asthma. , 1998, Chest.

[22]  M. Chan-yeung,et al.  Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. , 1996, American journal of respiratory and critical care medicine.

[23]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[24]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[25]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.